Skip to main content
. 2019 Oct 11;9:1056. doi: 10.3389/fonc.2019.01056

Table 8.

TNF-α and GSTs polymorphisms in response rate of MM patients.

Variable Response rate
CR+VGPR+PR+SD PD
p-value OR (95% CI)
ISS
I+II Reference
III <0.001 5.44 (2.14–13.84)
Auto-HSCT
Yes Reference
No 0.015 3.36 (1.22–9.25)
TNFα−308G>A
GG 1.0 1.02 (0.39–2.69)
GA+AA Reference
TNFα−238G>A
GG 0.45 0.69 (0.26–1.80)
GA+AA Reference
GSTT1
Present 0.60 0.74 (0.24–2.24)
Null Reference
GSTM1
Present 0.30 1.71 (0.61–4.80)
Null Reference
TNFα−308 and−238
GG+GG 0.76 0.66 (0.19–2.32)
GA+AA+GA+AA Reference
TNFα−308 and GSTT1
GG+present 0.41 0.30 (0.04–1.95)
GA+AA+null Reference
TNFα−308 and GSTM1
GG+present 0.90 1.19 (0.27–5.16)
GA+AA+null Reference
TNFα−238 and GSTT1
GG+present 0.93 0.56 (0.08–3.69)
GA+AA+null Reference
TNFα−238 and GSTM1
GG+present 0.50 3.12 (0.36–27.0)
GA+AA+null Reference

CR, complete response; VGPR, very good partial response; PR, partial response; SD, stable disease; PD, progressive disease patients, according to response criteria for MM (24, 25). The bold values represent significant values.